Affimed Therapeutics AG, of Heidelberg, Germany, named Adi Hoess CEO and appointed Rolf Guenther chief operating officer...and Alexander H. Burgess as vice president of marketing...CardioDx, of Palo Alto, Calif., named Andrew L. Guggenhime chief financial officer and appointed Mark Monane chief medical officer

Creabilis SA, of Luxembourg, named Alex Leech vice president and head of finance of operations, appointed James Sandy senior vice president and head of development and added Peter Spargo as senior vice president for chemistry, manufacturing and controls

Tim Henkel as executive vice president and head of R&D...Doug Gessl as chief operating officer and chief financial officer...and Lisa Wittmer as vice president of regulatory affairs

PharmacoFore Inc., of San Carlos, Calif., appointed Joseph Stauffer chief medical officer and vice president of corporate strategy and named Narinder Banait vice president of intellectual property...ProtAffin AG, of Graz, Austria, appointed Frank Walsh chairman and named Tim Edwards to the board

GenVec Inc., of Gaithersburg, Md., elected Adel A. F. Mahmoud and Edward M. Connor Jr...It also named Timothy D. Kasbe senior vice president and chief information officer...Medicure Inc., of Winnipeg, Manitoba, appointed Dawson Reimer president and chief operating officer

The people who are assigned to the committee include Michael Conte, William Marston, Richard Powell and Michael Smith...Ablexis LLC, of San Francisco, appointed Jake Bauer senior director of corporate development and business operations...Agennix AG, of Planegg, Germany, appointed Jill Porter senior vice president of pharmaceutical development and appointed Christine Boisclair senior vice president of global regulatory affairs

Vivo Ventures LLC, of Palo Alto, Calif., promoted Chen Yu and James Zhao to managing partners...Xceleron Ltd., of York, UK, appointed David Roblin to its board and named Stuart Best senior director of operations...XOMA Ltd., of Berkeley, Calif., appointed Paul Rubin vice president and chief medical officer

Spectrum Pharmaceuticals Inc., of Henderson, Nev., promoted Steven M. Fruchtman to vice president and chief medical officer and Nozar Azarnia to vice president of biostatistics and data management...Tetragenetics Inc., of Cambridge, Mass., appointed Marco Cacciuttolo president and CEO...It also named Ben Machielse and Robert Gailus to its board

Pacira Pharmaceuticals Inc., of Parsippany, N.J., appointed Laura A. Brege and Paul J. Hastings to its board...PolyTherics Ltd., of London, named John Burt CEO and board member after Keith Powell stepped down...Resolve Therapeutics LLC, of Seattle, named Peter Kiener chairman and added Somu Subramaniam as an observer to the board

It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board

Co-founder Douglas P. Clark was named chief medical officer and acting CEO, effective July 1...Compass Biotechnologies Inc., of Edmonton, Alberta, appointed Joseph Sinkule president and chief operating officer...Cytochroma Inc., of Markham, Ontario, appointed Cynthia Lavoie and Osamu Otani to its board

The firm also nominated Stuart Strathdee and Ganesh Kishore to its board...Immune Design Corp., of Seattle, named Carlos V. Paya CEO and board member...Medivation Inc., of San Francisco, appointed Gretchen Burke vice president of finance and business processes

An item in the May 19, 2011, edition of BioWorld Today's Appointments and Advancements column should have said that Adimab LLC appointed Frances Heller to its board

Addex Pharmaceuticals Ltd., of Geneva, added Hoyoung Huh and Oleg Nodelman to its board...Aileron Therapeutics Inc., of Cambridge, Mass., named Julian Adams, Scott Kapnick and John H. McArthur to its board, and named Stephen W. Fesik, Robert H. Grubbs and Michael Hanley to its scientific advisory board

Neoprobe Corp., of Dublin, Ohio, appointed Mark Pykett president and CEO...Regulus Therapeutics Inc., of La Jolla, Calif., named Lars Karlsson vice president of immunology and fibrosis...Tobira Therapeutics Inc., of Manalapan, N.J., named Andrew Hindman president and CEO

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations...Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Joshua D. Hamermesh vice president of business and corporate development...Lightlake Therapeutics Inc., of London, appointed Cynthia McCormick as senior clinical and regulatory advisor

Access Pharmaceuticals Inc., of Dallas, named Anthony Mottola vice president of managed care and market access...Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., appointed Mark D. McGregor chief financial officer and corporate secretary

KaloBios Pharmaceuticals Inc., of South San Francisco, added Jonathan Leff as chief medical officer and named Gary A. Lyons to its board...Labopharm Inc., of Laval, Quebec, elected Mark D'Souza president, CEO and board member...Pro-Pharmaceuticals Inc., of Newton, Mass., named Peter G. Traber president and CEO

Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member...ITherX Pharmaceuticals Inc., of San Diego, named Stefan Zeuzem chairman of its scientific and clinical advisory board